Neuroblastoma (NB) is a pediatric tumor of embryonic origin. About 1–2% of all NBs are
familial cases, and genetic predisposition is suspected for the remaining cases. During the …

Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system which
accounts for 8–10% of pediatric cancers. It is characterized by a broad spectrum of clinical …

High-risk neuroblastoma is a very aggressive disease, with excessive tumor growth and
poor outcomes. A proper stratification of the high-risk patients by prognostic outcome is …

Peripheral neuroblastic tumours (PNTs), a family of tumours arising in the embryonal
remnants of the sympathetic nervous system, account for 7–10% of all tumours in children. In …

Given the biological and clinical heterogeneity of neuroblastoma, risk stratification is vital to
determining appropriate treatment. Historically, most patients with high‐risk neuroblastoma …

Fractal characteristics of chromatin, revealed by light or electron microscopy, have been
reported during the last 20 years. Fractal features can easily be estimated in digitalized …

Simple Summary Neuroblastoma (NB) is the most frequent solid extracranial tumor in
children and the most frequently diagnosed cancer during infancy. A genetic modification, a …

Neuroblastoma is a peripheral neural system tumor that originates from the neural crest and
is the most common and deadly tumor of infancy. Here we show that neuroblastoma harbors …

Although intensive multimodal treatment has improved outcomes for patients with high-risk
neuroblastoma, the specific role of primary tumor resection remains controversial. Many …

Background Neuroblastoma (NB) is a paediatric tumour of the sympathetic nervous system.
Half of all cases are defined high-risk with an overall survival less than 40% at 5 years from …